BANCROFT ROBERT E. (PRESIDENT & CEO) received a stock award from AEON BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2026ACC: 0001104659-26-017726
DirectorOfficer· PRESIDENT & CEO
Since Feb 2026
+3M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3M acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+3M
Price / share
—
Trade value
—
% of position
1693.9%
2/17/2026
177.10K→3.18M
Total
Net shares
+3M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/17/2026 | A · Award | +3M | — | — | 1693.9% | 177.10K | 3.18M |
| Total | +3M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported